The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-((11-(4-Methylpiperazin-1-yl)-10,11-dihydrodibenzo[b,f]thiepin-2-yl)methyl)pivalamide ID: ALA1259158
PubChem CID: 49781894
Max Phase: Preclinical
Molecular Formula: C25H33N3OS
Molecular Weight: 423.63
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CN1CCN(C2Cc3ccccc3Sc3ccc(CNC(=O)C(C)(C)C)cc32)CC1
Standard InChI: InChI=1S/C25H33N3OS/c1-25(2,3)24(29)26-17-18-9-10-23-20(15-18)21(28-13-11-27(4)12-14-28)16-19-7-5-6-8-22(19)30-23/h5-10,15,21H,11-14,16-17H2,1-4H3,(H,26,29)
Standard InChI Key: CKLAPTDGXNWXQT-UHFFFAOYSA-N
Molfile:
RDKit 2D
30 33 0 0 0 0 0 0 0 0999 V2000
18.2259 -13.1978 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0301 -13.3989 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1904 -15.0583 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
17.5723 -14.5342 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5617 -13.7344 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8649 -13.3453 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1781 -13.7550 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1926 -14.5578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8899 -14.9433 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3630 -14.1462 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.9686 -14.9088 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4316 -15.6295 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2890 -15.5889 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6812 -14.8215 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2159 -14.1039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0481 -12.3922 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.6599 -11.8381 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4848 -11.0356 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6992 -10.7826 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.0883 -11.3386 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2631 -12.1475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5244 -9.9763 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4571 -13.3540 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7494 -13.7780 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.0300 -13.3771 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3219 -13.8003 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0175 -12.5522 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.6012 -13.3987 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3343 -14.6252 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6042 -14.2083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11 3 1 0
14 15 2 0
15 10 1 0
6 7 2 0
1 16 1 0
16 17 1 0
3 4 1 0
7 8 1 0
2 10 1 0
8 9 2 0
9 4 1 0
16 21 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
19 22 1 0
1 5 1 0
7 23 1 0
10 11 2 0
23 24 1 0
4 5 2 0
24 25 1 0
11 12 1 0
25 26 1 0
1 2 1 0
25 27 2 0
12 13 2 0
26 28 1 0
5 6 1 0
26 29 1 0
13 14 1 0
26 30 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 423.63Molecular Weight (Monoisotopic): 423.2344AlogP: 4.34#Rotatable Bonds: 3Polar Surface Area: 35.58Molecular Species: NEUTRALHBA: 4HBD: 1#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 8.03CX LogP: 4.79CX LogD: 4.08Aromatic Rings: 2Heavy Atoms: 30QED Weighted: 0.80Np Likeness Score: -0.74
References 1. Kristensen JL, Püschl A, Jensen M, Risgaard R, Christoffersen CT, Bang-Andersen B, Balle T.. (2010) Exploring the neuroleptic substituent in octoclothepin: potential ligands for positron emission tomography with subnanomolar affinity for α(1)-adrenoceptors., 53 (19): [PMID:20857909 ] [10.1021/jm100652h ]